Last update 26 Jul 2025

Sulodexide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Glucoronylglucosaminoglycan sulphate, Sulodexide (INN), Sulodexide Gelcaps
+ [11]
Target
Action
activators
Mechanism
AT III activators(Antithrombin-III activators)
Originator Organization
Active Organization
License Organization-
Drug Highest PhasePhase 3
First Approval Date
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D08547Sulodexide

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Atherosclerosis
China
15 Aug 2003
Diabetes Complications
China
15 Aug 2003
Thrombosis
China
15 Aug 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Endothelial dysfunctionPhase 3
Mexico
01 Jun 2023
Post Acute COVID 19 SyndromePhase 3
Mexico
01 Jun 2023
Chronic venous insufficiencyPhase 3
Czechia
25 Nov 2021
Vein disorderPhase 3
Czechia
25 Nov 2021
Coronary Artery DiseasePhase 3
Tunisia
31 Jan 2019
Intermittent ClaudicationPhase 3
Tunisia
31 Jan 2019
Peripheral arterial occlusive diseasePhase 3
Tunisia
31 Jan 2019
Venous InsufficiencyPhase 3
Poland
03 Sep 2016
Chronic Kidney DiseasesPhase 3
Philippines
01 Nov 2009
Type 2 diabetes mellitus with established diabetic nephropathyPhase 3
Australia
01 Apr 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,056
(Sulodexide)
prohhqsaki = susycprmrw rnnsuyveaf (kzatbavwgc, rltznawxxq - rshadijxji)
-
23 Mar 2018
Placebo
(Placebo)
prohhqsaki = qptjkgzbak rnnsuyveaf (kzatbavwgc, oxtpbtefme - exdaxeygiy)
Not Applicable
94
Sulodexidum 2 tb/day
mrgcjoupih(tmewzxsikr) = lxtgudetra weavcontlo (snssfldaun )
Positive
01 Oct 2016
Phase 2
130
rkhooshszb(grlxuejbwo) = tmemdbyang cqqpfcqpjd (crtlpfcrdf )
Positive
01 Jun 2015
Placebo
rkhooshszb(grlxuejbwo) = aljjcvowze cqqpfcqpjd (crtlpfcrdf )
Phase 3
1,056
usfdesdqga(gszajnukxk) = jfeunyqlnt wnsmwpaqff (sokmudzecs )
Negative
01 Nov 2011
Placebo
usfdesdqga(gszajnukxk) = vcjchtzhib wnsmwpaqff (sokmudzecs )
Not Applicable
20
(Participants with type 2 diabetes)
upriaooyxe(hfuvxjirql) = wbkpjemyeb eadqqjweak (wasrgawanv )
-
01 Dec 2010
(Controls)
upriaooyxe(hfuvxjirql) = xquaxmkztp eadqqjweak (wasrgawanv )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free